These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Agharazii M; St-Louis R; Gautier-Bastien A; Ung RV; Mokas S; Larivière R; Richard DE Am J Hypertens; 2015 Jun; 28(6):746-55. PubMed ID: 25430697 [TBL] [Abstract][Full Text] [Related]
23. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Watanabe H; Miyamoto Y; Honda D; Tanaka H; Wu Q; Endo M; Noguchi T; Kadowaki D; Ishima Y; Kotani S; Nakajima M; Kataoka K; Kim-Mitsuyama S; Tanaka M; Fukagawa M; Otagiri M; Maruyama T Kidney Int; 2013 Apr; 83(4):582-92. PubMed ID: 23325087 [TBL] [Abstract][Full Text] [Related]
24. Characterization of the Oxidative Stress in Renal Ischemia/Reperfusion-Induced Cardiorenal Syndrome Type 3. Caio-Silva W; da Silva Dias D; Junho CVC; Panico K; Neres-Santos RS; Pelegrino MT; Pieretti JC; Seabra AB; De Angelis K; Carneiro-Ramos MS Biomed Res Int; 2020; 2020():1605358. PubMed ID: 33102574 [TBL] [Abstract][Full Text] [Related]
26. Cross talk between mitochondria and NADPH oxidases. Dikalov S Free Radic Biol Med; 2011 Oct; 51(7):1289-301. PubMed ID: 21777669 [TBL] [Abstract][Full Text] [Related]
27. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease. Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852 [TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician. Montezano AC; Touyz RM Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098 [TBL] [Abstract][Full Text] [Related]
29. Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD. Pieniazek A; Bernasinska-Slomczewska J; Gwozdzinski L Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201270 [TBL] [Abstract][Full Text] [Related]
30. Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress. Rasool M; Ashraf MA; Malik A; Waquar S; Khan SA; Qazi MH; Ahmad W; Asif M; Khan SU; Zaheer A; Qaisrani MM; Khan AR; Iqbal A; Raza A; Iram S; Kamran K; Iqbal A; Mustafa MZ; Choudhry H; Zamzami MA; Abdulaal WH; Jamal MS PLoS One; 2017; 12(2):e0171561. PubMed ID: 28178330 [TBL] [Abstract][Full Text] [Related]
31. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease. Aminzadeh MA; Reisman SA; Vaziri ND; Shelkovnikov S; Farzaneh SH; Khazaeli M; Meyer CJ Redox Biol; 2013; 1(1):527-31. PubMed ID: 24363993 [TBL] [Abstract][Full Text] [Related]
32. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels. Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B Nephron; 2015; 131(3):167-74. PubMed ID: 26426087 [TBL] [Abstract][Full Text] [Related]
33. Modulation of mitochondria and NADPH oxidase function by the nitrate-nitrite-NO pathway in metabolic disease with focus on type 2 diabetes. Schiffer TA; Lundberg JO; Weitzberg E; Carlström M Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165811. PubMed ID: 32339643 [TBL] [Abstract][Full Text] [Related]
34. Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. Dikalov SI; Nazarewicz RR Antioxid Redox Signal; 2013 Oct; 19(10):1085-94. PubMed ID: 22443458 [TBL] [Abstract][Full Text] [Related]
35. Is oxidative stress a therapeutic target in cardiovascular disease? Münzel T; Gori T; Bruno RM; Taddei S Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801 [TBL] [Abstract][Full Text] [Related]
36. Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread. Duni A; Liakopoulos V; Roumeliotis S; Peschos D; Dounousi E Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362427 [TBL] [Abstract][Full Text] [Related]
37. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase. Shen GX Can J Physiol Pharmacol; 2010 Mar; 88(3):241-8. PubMed ID: 20393589 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation. Ren X; Wang X; Yuan M; Tian C; Li H; Yang X; Li X; Li Y; Yang Y; Liu N; Shang H; Gao Y; Xing Y Curr Pharm Des; 2018; 24(26):3062-3071. PubMed ID: 30179130 [TBL] [Abstract][Full Text] [Related]
39. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Sautin YY; Nakagawa T; Zharikov S; Johnson RJ Am J Physiol Cell Physiol; 2007 Aug; 293(2):C584-96. PubMed ID: 17428837 [TBL] [Abstract][Full Text] [Related]
40. Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells. Richter B; Haller J; Haffner D; Leifheit-Nestler M Pflugers Arch; 2016 Sep; 468(9):1621-35. PubMed ID: 27448998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]